Senseye's OBCI Diagnostic Tool for PTSD

Stopped early

Conditions studied: PTSD

In brief

This pilot study will investigate the feasibility, acceptability, repeatability, accuracy and efficacy of the Senseye OBCI diagnostic tool to assess the presence and severity of PTSD symptoms and monitor response to trauma-informed interventions. A total of 68 adults will be included in the study with a follow-up time point of 9 weeks post-initial intervention.

Key facts

Study ID

NCT05372523

Run by

Senseye, Inc.

People needed

61

Starts

2022-04-25

Expected to finish

2023-01-11

Last updated by the study team

2023-04-12

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male/Female diagnosed with PTSD (only for PTSD group)
• aged 18- 65 years old
• able to read/write in English

You may not qualify if…

• presence of intellectual disabilities
• psychotic or self-injurious behavior
• seizure disorder
• major depression
• traumatic brain injury (TBI)
• language disorder
• eye disorders
• other neurodevelopmental disorders
• history of lifetime psychosis
• mania
• current suicidality
• diagnosis of a substance use disorder
• impaired functioning to the degree that requires immediate initiation of psychotropic medication.

Where it is running

• Olive View - UCLA Medical Center — Sylmar, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.